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The recruitment of blood-born leukocytes to a specific site of infection is one of the 
most fundamental of all inflammatory processes. To successfully elicit the appropriate 
leukocyte populations, a number of dynamic alterations must first occur in a tightly 
coordinated manner. The first changes that are evident involve alterations in the 
endothelium as this structure is converted from a passive to an active role in inflamma- 
tion.’.’ The changes that occur in the endothelium are important in localizing the 
circulating leukocytes to a restricted area of injury where the infectious process is 
originating. The actual mechanism(s) that leads to the generation of an “inflamed” 
or activated endothelium is likely multifactoral. Bacteria-derived products, such as 
lipopolysaccharide (LPS), can serve as powerful agents for stimulating endothelial 
cells.* In addition, early response cytokines, including interleukin- 1 alpha (IL- la), 
interleukin-1 beta (IL-lp), and tumor necrosis factor alpha (TNFa), are also classic 
mediators that can activate the endothelium.’ Interestingly, LPS can either directly 
stimulate or indirectly activate endothelial cells by induction of resident, tissue macro- 
phage-derived IL- 1 or TNF.3,4 Expression of these cell-derived mediators can establish 
a cytokine network necessary to fully drive the inflammatory respon~e .~ .~  Independent 
of an exogenous (LPS) or endogenous (IL- 1 or TNF) signal, activation of the endothe- 
lium results in the expression of adhesion molecules on the surface of endothelial 
cells and leukocytes. The net result of this interaction is the localization of specific 
leukocyte populations to an area of tissue injury. Elegant studies have demonstrated 
that the endothelial cell-leukocyte adhesion process is comprised of discrete steps, 
which include an initial “rolling” event followed by tenacious binding by strong 
leukocyte-to-endothelial cell interactions. Once tethered to endothelial cells in a local 
area of tissue injury, the leukocyte must next traffic out of the vessel lumen, move 
through the basement membrane, and successfully amve at the inflammatory site. 
Thus, binding of leukocytes to the endothelium is a transient event. 
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CHEMOTACTIC FACTORS 
Whereas events involved in the initial binding of leukocytes to an activated 
endothelium are becoming increasingly clear, the actual movement of certain leuko- 
cyte populations from the vasculature to an exact site of tissue injury is not well 
understood. However, recent information suggests that specific targeting and move- 
ment of leukocytes involve the further participation of adhesion molecules and chemo- 
tactic factors often expressed by stromal and other resident tissue cells. The idea that 
leukocytes follow chemical signals is not new, as historic studies have identified 
chemotactic factors that can induce the directed migration of leukocytes. For example, 
bacterial peptides (fmetleuphe), polypeptides (C5a), and lipids (LTB and PAF) have 
all demonstrated the ability to elicit various leukocyte  population^.^-^ There is little 
doubt that these chemotactic factors play an important role in the initiation of leukocyte 
recruitment; however, their transient expression, instability, and lack of cell specificity 
have always left a void in the total explanation of the chemotactic response. The 
finding that many chemotactic factors possess little specificity for eliciting specific 
leukocyte populations has been inconsistent with the histopathology of a number of 
diseases. For example, acute inflammatory reactions are often characterized by the 
presence of polymorphonuclear leukocytes, whereas other chronic inflammatory dis- 
eases are characterized by mononuclear cell infiltration. Further understanding of the 
mechanism of this biologic response has been attained by studies assessing the role 
of chemotactic cytokines or chemokines in mediating leukocyte elicitation.'"'' 
The first chemotactic cytokine to be discovered was originally termed monocyte- 
derived neutrophil chemotactic factor (MDNCF) and later classified as interleukin- 
8 (IL-8).I3 Subsequent studies proved that most nucleated cells, when appropriately 
stimulated, have the capacity to generate IL-8.Ib1' As research in the chemotactic 
cytokine arena progressed, it became increasingly apparent that IL-8 was only one 
member of a supergene family that possesses chemotactic activity for polymorphonu- 
clear (PMN) leukocytes." Presently, chemokines that possess chemotactic activity 
for PMNs include epithelial cell-derived neutrophil activating peptide (ENA-78), 
neutrophil-activating peptide-2 (NAP-2), growth-related oncogene (GRO-alpha, beta, 
and gamma), and macrophage inflammatory protein-2 alpha and beta (MIP-2 (Y and 
p). This supergene family of chemotactic cytokines is structurally characterized by 
the conserved location of two of four cysteine residues. The first two cysteines are 
separated by one additional amino acid; therefore, this family is often referred to as 
the C-X-C chemokine family. The aforementioned chemotactic factors also share a 
common amino acid motif, ELR (glutamic acid, leucine, and arginine), which is 
present in juxtaposition to the first NH,-terminal cysteine amino of the C-X-C.Io The 
importance of the ELR is that this sequence is responsible for neutrophil activation 
via receptor ligand interactions. Interestingly, other C-X-C supergene family members 
that do not possess the ELR motif are not chemotactic for neutrophils. These polypep- 
tides include platelet factor-4 (PF-4) and an interferon-inducible protein (IP-10). 
Recent investigations demonstrated that generation of recombinant PF-4, which has 
been mutated to include the ELR, is indeed chemotactic for neutrophils. On the 
contrary, ELR-containing chemokines that have been truncated to remove the ELR 
element dramatically change their binding affinity for the appropriate receptor, subse- 
quently reducing their chemotactic activity. However, the synthesis of short peptides 
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that include the ELR motif is not active, suggesting that interaction of other domains 
of the chemokine molecule is necessary for biologic activity. The receptor system 
for the C-X-C chemokines is comprised of two high affinity receptors. One is promis- 
cuous and able to interact with other family members, whereas the other receptor 
possesses specificity for an individual chemokine. The chemokine receptors are seven 
transmembrane-spanning proteins that signal via GTP-binding proteins. 
Whereas the IL-8 or C-X-C supergene family possesses chemotactic activity 
mainly for neutrophils, a related polypepide family has been discovered with activity 
predominantly for mononuclear cells. This class of chemokines is also structurally 
identified by the location of two of four cysteines. However, the first two cysteines 
are in juxtaposition and this family is designated as the C-C chemokine family.ll 
Monocyte chemoattractant protein- I ,  2, and 3 (MCP-1, MCP-2, and MCP-3), macro- 
phage inflammatory protein-I (MIP-1) alpha and beta, and RANTES are members 
of this family of chemotactic cytokines. Recent data suggest that the 1igand:receptor 
system for the C-C family is similar to the C-X-C system. Structure/function analysis 
of these chemokines and the quest for receptor antagonists have greatly accelerated 
interest in this area of inflammation. 
EXPRESSION AND REGULATION OF CHEMOTACTIC 
CYTOKINES 
A striking novel aspect of both the C-C and C-X-C chemokine families is the 
expression pattern that results in the generation of these mediators. Both inflammatory 
and noninflammatory cells have been identified as cell sources of these chemotactic 
factors. Thus, neutrophils, monocytes, smooth muscle cells, fibroblasts, epithelial 
cells, and endothelial cells have all been identified as rich sources of chemokines, 
especially IL-8."'7 Although these cells do not usually generate high levels of 
IL-8 during resting conditions, they can produce elevated concentrations when stimu- 
lated with an appropriate agonist. One exception is the expression of IL-8 by certain 
tumor cell lines which possess the ability to constitutively generate significant levels 
of IL-8. Two of the most potent agents for the induction of IL-8 are IL-1 and TNF. 
These early response cytokines induce the production of IL-8 by most nucleated cells 
at picomolar to nanomolar concentrations. Although IL-1 and TNF are potent early 
response cytokines that are able to induce IL-8 expression, other cytokines such as 
interleukin-6 (IL-6) do not serve as effective signals for the production of IL-8. Thus, 
expression of IL-8 depends on both cell and stimulus ~pecificity.~." LPS and other 
bacteria-derived products can also serve as important activating agents for the produc- 
tion of IL-8; however, LPS-dependent IL-8 production is not routinely observed from 
all cells. Although both mononuclear phagocytes and polymorphonuclear leukocytes 
can generate IL-8 in response to LPS, most noninflammatory cells do not generate 
IL-8 in response to bacteria-derived products. 
The inability of LPS to activate specific cells to produce IL-8 does not imply 
that Gram-negative bacteria are not involved in the process of generating chemotactic 
cytokines. Evolving scientific information suggests that generation of cytokine net- 
works via LPS-dependent mechanisms is a major pathway for the production of 
chemokine~.'.~ During the pathogenesis of an infectious process, it is likely that 
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bacterial products activate sentinel, resident macrophages which are ubiquitously 
dispersed throughout tissue. This activation event results in the production of early 
response cytokines (IL-1 and TNF), which can “network” with surrounding resident 
tissue cells and orchestrate the production of more distal cytokines, including IL-8. 
Therefore, the overall effect of the inciting agent is to activate the inflammatory 
cascade and cause the up-regulation of appropriate chemotactic factors to insure 
the successful elicitation of leukocytes to the area of inflammation. Interestingly, 
noninflammatory cells such as stromal and epithelial cells can no longer be only 
designated as targets of the inflammatory response, but are more likely to be considered 
as effector cells via the expression of important cytokines. This scenario was pre- 
viously shown to be active in the generation of lung and hepatic chemotactic cytokines 
using in vitro models. For example, the conditioned media from LPS-challenged 
alveolar macrophages, recovered from nonsmoking, disease-free volunteers, pos- 
sessed significant activity in stimulating the expression of IL-8 from pulmonary 
 fibroblast^.^ These same lung fibroblasts were not susceptible to LPS stimulation, 
suggesting that factors(s) in the alveolar macrophage-conditioned media were provid- 
ing the signal for noninflammatory cell activation. Similar results were observed 
using type 11-like pneurnocyte cell lines challenged with conditioned media from 
LPS-treated alveolar macrophages.6 Further studies identified that both IL- 1 and TNF 
are involved in the expression of IL-8 from these noninflammatory cells. In these 
studies, conditioned media from alveolar macrophages treated with neutralizing anti- 
bodies to IL-1 or TNF significantly reduced the production of fibroblast-derived 
IL-8. This networking phenomenon is not restricted only to the lungs, as previous 
studies demonstrated that cytokine networking can also occur in the liver. These 
investigations showed that LPS-activated Kupffer cells can secrete both IL- 1 and 
TNF which can interact with hepatocytes and induce the production of IL-8 from 
these noninflammatory cells. It is becoming increasingly clear that this pathway of 
cell activation leading to the production of a potent chemotactic factor for neutrophils 
is likely a mechanism for leukocyte elicitation common to all tissues. Stimulated 
resident macrophages signal the surrounding normal resident cells to produce a 
chemoattractant that elicits a specific population of leukocytes to a local area of 
inflammation. This scenario is a key component of leukocyte elicitation, as it insures 
that the recruitment response is timely, specific, and localized only to the area of 
tissue injury. This latter phenomenon is one of the most fundamental aspects of 
normal inflammation. 
NEUTROPHIL-DEPENDENT CHEMOKINE EXPRESSION 
In acute inflammation, the first blood-born leukocyte to arrive at a site of tissue 
injury or infection is the neutrophil. Historically, these elicited cells have been 
important in clearing infectious agents by the release of proteolytic enzymes and 
reactive oxygen metabolites. In addition, these terminally differentiated leukocytes 
have classically been viewed as possessing limited protein-synthesizing activity. 
Recent studies showed that neutrophils can produce polypeptides, including heat 
shock proteins, elastase, plasminogen activator, cytoskeletal proteins, and cell surface 
receptors. Also, stimulated neutrophils have the ability to generate cytokines, that 
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are important in maintaining the inflammatory response, such as colony-stimulating 
factors (G-CSF and GM-CSF), interferon-alpha, interleukin-6, interleukin- I ,  tumor 
necrosis factor, and interle~kin-8.2'-*~ The production of these polypeptide mediators 
at a site of injury is likely to play a significant role in the subsequent evolution of 
inflammation by both paracrine and autocrine interactions, involving other leukocytes 
andor noninflammatory cells. 
Investigations have demonstrated that neutrophils are capable of generating 
IL-8 in response to both endogenous and exogenous signals. For example, the phago- 
cytic response to zymosan or other particulate material, as well as LPS, may serve 
as an exogenous agent for neutrophil-derived IL-8. In addition, the adherence response 
is a significant signal which may lead to the production of IL-8. The mechanism(s) 
involved in adherence-dependent IL-8 expression may be an adhesion molecule- 
mediated event, as freshly isolated neutrophils in suspension did not express steady- 
state levels of IL-8 mRNA or release antigenic IL-8. The concomitant treatment of 
neutrophils with actinomycin D also blocked any adherence-induced IL-8 mRNA 
and protein. Subsequent investigations showed that adherence-induced, neutrophil- 
derived IL-8 is under the regulation of repressor proteins. This was ascertained by 
the concomitant addition of cycloheximide to neutrophils undergoing adherence, 
resulting in the superinduction of IL-8 mRNA. 
Whereas exogenous stimuli can cause neutrophils to generate IL-8, other endoge- 
nous mediators are highly effective in generating neutrophil-derived IL-8. In particu- 
lar, IL-1 and TNF were effective stimulating agents for neutrophils in both a time- 
and dose-dependent manner. The findings that IL- 1 can stimulate neutrophil-derived 
IL-8 is intriguing in light of reports demonstrating that IL- 1 is not a potent neutrophil- 
activating compound for direct chemotaxis, exocytosis, or enzyme release. However, 
IL-1 can induce neutrophils to generate a potent neutrophil chemoattractant, which 
is likely to perpetuate the recruitment process. Other factors have also been identified 
as important neutrophil-activating agents and play both direct and indirect roles in 
leukocyte recruitment. C5a, fMLP, and LTB4 are all known mediators of neutrophil 
recruitment that also synergize in the presence of LPS to induce neutrophil-derived 
IL-8. The synergistic activity of bacteria-derived products plus traditional neutrophil- 
activating agents such as C5a, fMLP, and LTB4 could aid in explaining the rapid 
elicitation of neutrophils to a site of bacterial infection. At the inflammatory lesion, 
neutrophils can encounter host-derived cytokines (IL- I and TNF), endogenous chemo- 
tactic and activating agents (C5a, fMLP, and LTB4), as well as bacteria and their 
products, which can stimulate neutrophils in a synergistic manner for the production of 
neutrophil-derived IL-8. Although the aforementioned classic neutrophil chemotactic 
factors (C5a, fMLP, and LTB4) are indeed chemotactic agents, these agonsts have 
relatively short half-lives. Thus, local generation of IL-8 by mononuclear phagocytes, 
noninflammatory cells, and neutrophils may sustain the inflammatory response 
through continued neutrophil recruitment and activation. The importance of the neu- 
trophil as an effector cell via de nova cytokine production places this inflammatory 
cell in a pivotal position to aid in the orchestration of conventional immune responses. 
Although increasing evidence supports the role of the neutrophil as an important 
cytokine-producing leukocyte, less is known about the mechanism(s) that regulates 
the expression of these neutrophil-derived polypeptides. Interestingly, specific com- 
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pounds that control the production of monocyte-derived cytokines also appear to 
have a regulating influence on neutrophil-derived cytokines. 
Dexamethasone, interleukin-4 (IL-4), and interleukin- 10 (IL- 10) have been dem- 
onstrated in a time- and dose-dependent manner and in a delayed addition manner 
to regulate the production of neutrophil-derived IL-8. Neutrophils treated with LPS 
and dexamethasone at 100, 10, and 1 nM demonstrated a 73%, 47%, and 45% 
reduction, respectively, in IL-8 levels. Concentrations of dexamethasone less than 1 
nM failed to cause any further suppression of neutrophil IL-8 in response to LPS. 
In similar studies, IL-4 and IL-10 exerted a suppressive effect on neutrophil IL-8 
production over a concentration range of 100 pg/ml to 100 ng/ml. Further studies 
demonstrated that the delayed addition of dexamethasone, IL-4, or IL-10 could still 
dramatically influence the production of neutrophil-derived IL-8. The production of 
IL-8 from neutrophils stimulated with LPS at time 0 and given either of the three 
suppressing agents 2 hours later was still significantly inhibited at the final 18-hour 
time-point. Additional studies demonstrated that the suppressive effects of IL-4, 
IL- 10, and dexamethasone were at the transcriptional level. Northern blot analyses 
of neutrophils challenged with LPS plus one of the three immunomodulating agents 
showed that steady-state levels of IL-8 were significantly reduced as compared to 
LPS alone. These studies are significant in that they demonstrate the regulation of 
neutrophil-derived IL-8 at the transcriptional level. 
The foregoing investigations are of interest, because IL-4 and IL- 10 are phenotypi- 
cally expressed by TH2 lymphocytes and have been shown to possess pleiotropic 
activities in a number of cell systems. Although IL-4 was originally described as a 
B- and T-cell maturation and growth factor, it has also been reported to have the 
dual role of either enhancing or suppressing monocyte functions. Interleukin-4 can 
also enhance monocyte major histocompatibility complex expression and augment 
tumoricidal activity. In contrast, IL-4 has been shown to block the generation of 
monocyte-derived cytokines, including IL-6, IL-8, TNF, and IL-I, as well as to 
reduce the generation of reactive oxygen metabolites. Whereas IL-4 can inhibit 
important phagocyte functions, it appears to be a general activating agent for endothe- 
lial cells. This cytokine can stimulate endothelial cells to induce the expression of 
specific adhesion molecules for lymphocytes and monocytes but not neutrophils, 
suggesting that IL-4 is important in driving the switch from an acute to a chronic 
inflammatory response. These studies demonstrating a reduction of IL-8 by 
IL-4-treated neutrophils support this hypothesis, as the continued generation of 
IL-8 would propagate the acute inflammatory response by continued neutrophil 
recruitment. 
Interleukin-10 may mechanistically play a key role in the leukocyte switch in a 
manner similar to that of IL-4. Originally, IL-10 was found to be able to inhibit the 
production of gamma interferon from CD4' T cells; however, this cytokine can also 
suppress a number of cytokines necessary to maintain an inflammatory response. 
Monocytes treated with LPS in the presence of graded doses of IL-10 produced 
significantly less IL-I, TNF, IL-6, IL-8, and G-CSF. In addition, IL-10 can suppress 
macrophage cytotoxic activity, parasite killing, and macrophage-derived nitric oxide 
production. Thus, the cytokine networks that function in both a positive and negative 
manner for the production and regulation of IL-8 are an important yet complex 
system. 
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BACTERIAL INFECTIONS AND IL-8 EXPRESSION 
Cytokines unquestionably represent an important communication link necessary 
to combat infectious processes. Previous studies identified cytokines, such as TNF, 
IL- I ,  and It-6, as being elevated in infectious disease states and suggested that they 
are indicators of clinical severity. Although these cytokines undoubtedly play a role 
in disease progression, other chemotactic cytokines appear to be involved in the 
initiation and maintenance of bacterial infection. Elevated concentrations of IL-8 
were identified after injection of intravenous Escherichia coli in primates and after 
an injection of LPS into human volunteer~.2’~?~ The kinetics of the in vivo expression 
pattern for IL-8 was similar to that for IL-6 in that the detection of IL-8 was delayed 
about 3 hours postchallenge. These data suggest that in vivo cytokine networking 
could account for the mechanism of IL-8 production, because IL-8 production was 
distal to the acute production of TNF in these experiments. 
Recently, IL-8 levels were identified in human patients with either severe bacterial 
infections, septicemia, or adult respiratory distress syndrome. A detailed longitudinal 
study assessing the plasma concentrations of TNF, IL-6, and IL-8 was reported for 
patients with meli0idosis.2~ This infection is caused by Pseudornonus pseudomallei 
and is endemic throughout Southeast Asia. Clinically, melioidosis caused a serious 
septicemic illness with a 40% death rate. In this study, 18 patients were monitored 
for circulating levels of plasma IL-8, IL-6, and TNF. Elevated concentrations of 
plasma IL-8 were found in 8 of 18 subjects, including four who subsequently died. 
Three of the four who died had the highest levels of IL-8, 161-362 pg/ml; therefore, 
IL-8 levels may have value as a predictor of mortality. Qualitative plasma IL-6 levels 
followed a pattern similar to those of IL-8 in that the highest levels of IL-6 were 
found in three of the four patients who died of this disease. On the contrary, no 
correlation was noted between plasma TNF levels and concentrations of IL-8 or 
IL-6. Additional clinical studies demonstrated a close correlation between plasma 
levels of TNF, IL-6, and IL-8 and the pathophysiology of the Jarisch-Herxheimer 
reaction (J-HR) associated with the treatment protocol for certain infectious  disease^.^' 
In this clinical study, 14 of 17 patients (82%) diagnosed with relapsing fever due to 
Borrelia recurrentis and treated with penicillin subsequently experienced J-HR. This 
acute reaction is characterized by rigors, fever, leukopenia, and a decrease in mean 
arterial blood pressure. Although no fatalities occurred, plasma TNF, IL-6, and 
IL-8 levels rose seven, six, and fourfold, respectively, over admission levels. Interest- 
ingly, a pulsatile release of the three different cytokines was associated with J-HR 
which occurred between 2 and 4 hours after antibiotic treatment. The peak values 
for TNF, IL-6, and IL-8 were 126 * 38, 9,578 * 1,808, and 8,102 * 4,491 pg/ml, 
respectively. 
In further studies, 105 of 151 patients undergoing mechanical ventilation in an 
intensive care unit had detectable IL-8 levels in bronchial  secretion^.^' However, 
IL-8 levels could not be detected in arterial blood, mixed venous blood, or urine 
samples. The occurrence of IL-8 in bronchial secretions of the pulmonary air space 
was significantly associated with patients with multiple injuries and nosocomial 
pneumonia. Interestingly, 66% of the patients who had positive IL-8 levels were 
diagnosed as having nosocomial pneumonia. Most of the patients tested positive for 
IL-8 within the first 36 hours of admission, suggesting that the production of IL-8 
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was a relatively rapid event. In addition, detectable IL-8 levels were associated with 
significant pulmonary dysfunction, as evidenced by static lung compliance and a low 
Pa02/FI02 ratio. 
Finally, recent investigation of 29 patients with adult respiratory distress syndrome 
(ARDS) demonstrated a significant correlation between the early appearance of 
IL-8 in the bronchoalveolar lavage (BAL) fluid and the development of clinical 
ARDS.32 The 29 patients were grouped into three at-risk categories: multiple trauma, 
perforated bowel, and pancreatitis. Both BAL and plasma from each patient were 
assessed for antigenic IL-8 within a mean of 2 hours of trauma, 34 hours of diagnosed 
pancreatitis, and 33 hours of diagnosed perforated bowel. Although no significant 
difference was noted between the groups in plasma IL-8 levels, a significant difference 
was found in the BAL fluid IL-8 levels in the group that progressed to ARDS as 
compared to the non-ARDS group value = 0.0006). Patients with clinical ARDS 
had IL-8 levels of 3.06 ng/ml versus 0.53 ng/ml in the non-ARDS group. 
Immunocytochemical analyses for antigenic IL-8 demonstrated more intense stain- 
ing of alveolar macrophages from patients who subsequently progressed to ARDS 
than of alveolar macrophages from non-ARDS patients. The latter findings support 
the concept that activated alveolar macrophages are a potent source of cytokines, 
such as IL-8, during the initiation of ARDS. These findings suggest that measurement 
of IL-8 levels in the BAL fluid of at-risk patients could aid in early identification 
of those likely to progress to ARDS. 
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